Our office will be closed Thursday, November 24th (all day) in observance of Thanksgiving Day. We will reopen on Friday, November 25th, at 8:30 am.

800-926-3775

University at Sea®

5700 4th Street North
St. Petersburg, FL 33703

E-Mail Us

Office Hours
Monday - Friday
9:00am - 5:00pm EST
Saturday
10:00am - 2:00pm EST
Cruise Conference Planning For Your Association

Current Topics in Cardiology, Lipidology, and Women’s Health & Bioethics and End-of-Life Decision Making; Cannabinoid Medicine

7-Night Eastern Caribbean New Year's Cruise
Round-trip Ft. Lauderdale, Florida
December 28 - January 04, 2025
<em>Celebrity Apex</em>
Celebrity Apex
16.0 AMA PRA Category 1 Credits™
16 ACPE Credits
2.0 Hours of Pharmacology for Nurse Practitioners
16.0 Contact Hours
Course Fees
$995 for Physicians, Attorneys, Psychologists, Doctors of Pharmacy, & Dentists
$750 for Physician Assistants
$595 for Nurses, Residents, Students & Others

Target Audience
Physicians, Physician Assistants, Nurses, Nurse Practitioners, Pharmacists
Program Purpose / Objectives
  1. Dying and the Patient With Decision Making Capacity
    • "Define "advance directives" and identify their purposes
    • Differentiate between instructional and decisionmaker advance directives
    • Distinguish advance directives from physician orders such as DNRs and POLSTs
    • Identify contemporaneous (not advance) choices for end-of-life care that patients may make when terminally ill.
  2. When the Patient Lacks Capacity (With or Without An Advance Directive)
    • Explain state laws that permit family members or others to make decisions on behalf of incapacitated patients
    • Analyze decision making standards governing those decisionmakers
  3. Palliative Care and Hospice
    • Explain the difference between palliative care and hospice
    • Explain Medicare requirements for coverage of hospice care, both the traditional rules and the new value-based rules
    • Evaluate patients' requests or suggestions of hospice care made by other members of the are team or by hospice providers themselves
  4. Death by Neurological Criteria
    • Explain how and why the law began recognizing medical professionals' use of neurological criteria to declare death
    • Explain multiple types of objections raised by the family members of patients physicians believe are dead by neurological criteria or may be subject to testing for satisfaction of the requirements of death by neurological criteria
    • Differentiate among various positions being taken during discussions of revision of the criteria to be satisfied
  5. Futility: When Some Clinicians Favor Termination of Treatment But Others, or Family Members, Don't
    • Explain the concept of medical futility
    • Compare state laws describing specific procedures and time periods applicable when clinicians view a patient's treatment as futile with state laws that are less specific
    • Prepare for potential health care team members' or families objecting to withholding or withdrawal of life-sustaining treatment the majority of the team views as futile
  6. Beyond Withholding and Withdrawing
    • Differentiate between medical aid in dying/medically assisted suicide and euthanasia
    • Explain the range of statutory requirements in states legalizing the practice
    • Identify trends in revisions to those state laws over time, as they guide practice
  7. Case Discussions and Debriefing
    • Apply what was learned about end-of-life treatment choices to case studies
    • Evaluate the relevance of principles discussed to attendees' practices
    • Consider and respond to the viewpoints of other health care professionals, thus setting the stage for similar discussion as appropriate with interprofessional health care teams outside of the instructional setting
  8. Update on LDL-C Management for Cardiovascular Disease Prevention: New toos and new targets in the new era
    • Review the approach to ASCVD risk assessment, which is key to matching the intensity of LDL-C lowering therapy with the absolute risk of the patient
    • Discuss the recommended patient groups for statin therapy
    • Review the mechanism of action for the newer FDA-approved non-statin lipid lowering agents
    • Discuss the new 2022 American College of Cardiology (ACC) Expert Decision Pathway, which provides guidance on statin alternatives in patients with ASCVD, including those with Familial Hypercholesterolemia (FH)
  9. Female specific risk factors that enhance women’s cardiovascular risk throughout the lifespan
    • Discuss unique cardiovascular risk factors that affect female patients and how to apply them to cardiovascular risk assessment to implement prevention and treatment strategies
  10. Microvascular angina, coronary microvascular dysfunction and INOCA (ischemia with non-obstructive coronary arteries) – from diagnosis to treatment
    • Discuss how to diagnosis coronary microvascular dysfunction (microvascular angina) and discuss prevention and treatment strategies
    • Review the recommended approach to chest pain in women, and INOCA specifically, as outlined in the 2022 American Heart Association Chest Pain guidelines
  11. Chronic Kidney Disease and cardiovascular risk: protecting the heart and the kidney
    • Evaluate for and monitor CKD in patients with T2D and cardiac disease
    • Discuss the 2022 Kidney Disease Improving Global Outcomes (KDIGO) guideline for management of T2D in patients with CKD, with a focus on how to incorporate SGLT2 inhibitors and non-steroidal MRAs into management plans for patients with CKD, T2D, and CVD
  12. Aspirin and other antiplatelet therapy for cardiovascular disease prevention: a tight rope between preventing vascular events and avoiding bleeding.
    • Review the mechanism of action of antiplatelet therapy
    • Describe indications for antiplatelet therapy
    • Explain risks and benefits of holding or de-escalating therapy
    • Discuss how to assess a patient for the balance between managing ischemic risk and reducing risk for bleeding
  13. Obesity Management for Reducing Cardiovascular Risk
    • Review the cardiovascular risks associated with obesity
    • Summarize the benefits and challenges associated with lifestyle, bariatric, and historical pharmacologic interventions in the treatment of obesity, before focusing on the available evidence for the newer glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications in the management of obesity and potential implications for reducing CVD risk
  14. Recent Updates in Hypertriglyceridemia Management for Cardiovascular Disease Prevention
    • Discuss lifestyle approaches to managing hypertriglyceridemia
    • >li>Discuss elevated triglycerides as a risk enhancing factor that would favor initiation of statin treatment
    • Discuss the trials investigating fibrate therapy and omega-3 fatty acid therapy for ASCVD prevention in persons with hyperglyceridemia
    • Discuss current cardiology consensus recommendations for management of ASCVD risk reduction in patients with persistent hypertriglyceridemia, which endorse the use of IPE in statin-treated patients at high cardiovascular risk who have triglycerides >135 mg/dL
Conference Sessions generally take place on days at sea (as itinerary allows), giving you plenty of time to enjoy your meals, evenings and ports of call with your companion, family and friends.
IMPORTANT NOTE: All conferees, their families, and guests must book their cruise within the University at Sea® meeting group through University at Sea® at 800-926-3775 or by registering online. This ensures our company can provide conference services and complimentary social amenities to all meeting participants and their guests. Thank you for your cooperation.
Faculty

Kathy L. Cerminara, JD, LLM, JSD

Kathy L. Cerminara, JD, LLM, JSD
Professor of Law Emerita
Shepard Broad College of Law
Nova Southeastern University
Ft. Lauderdale, FL Professor Kathy Cerminara bridges the medical and legal professions with her work on patients' rights in the end-of-life decision-making arena. She co-authors the nationally known treatise, The Right to Die: The Law of End-of-Life Decision making, and is a reviewer for several medical and medical-legal journals. Her scholarship most recently has focused on the intersection between end-of-life care, palliative care, and health care coverage policy. At the Nova Southeastern University Shepard Broad College of Law, she is a full professor. She is also an affiliate faculty member at NSU's Dr. Kiran C. Patel College of Allopathic Medicine.

Professor Cerminara teaches Health Policy & Bioethics, Bioethics and Law and Medicine seminars, Mental Health Law, and other health-law-related courses, in addition to Torts, Civil Procedure, and Administrative Law. She also created and was the initial director of the online Master of Science in Health Law program for non-lawyers.

Professor Cerminara has enjoyed nation and international recognition for her scholarship and service. Most recently, she was awarded the 2023 Distinguished Health Law Service Award from the Association of American Law Schools' Law, Medicine & Health Care Section. In 2017, she received a Scholars Award for innovative interprofessional work with the Broward County Mental Health Court. In 2013, she earned an American Health Lawyers Association 2012 Pro Bono Champion award for co-organizational work on Wounds of War: Meeting the Needs of Active-Duty Military & Veterans With Post-Traumatic Stress Disorder, a symposium taking place at NSU law school on February 1, 2013.

Additionally, since 2012, she frequently has been a member of the International Scientific Committee for the International Academy of Law & Mental Health, based in Montreal, Canada. In that position, she has co-organized the stream of therapeutic jurisprudence presentations for four of the Academy's bi-annual Congresses: one in Amsterdam in 2013, one in Vienna in 2015, one in Prague in 2017, and one in Rome in 2019. In recognition of that work, in 2017, the International Society of Therapeutic Jurisprudence awarded her and her co-organizer the first-ever Wexler/Winick Distinguished Service Award in Prague.

Prior to joining the College of Law faculty, Professor Cerminara taught at the University of Miami School of Law and St. Thomas University School of Law, clerked in the Western District of Pennsylvania and the United States Court of Appeals for the Third Circuit, and practiced law with Reed Smith Shaw & McClay in Pittsburgh, Pennsylvania.

Professor Cerminara received her J.D. magna cum laude from the University of Pittsburgh and her LL.M. and J.S.D. from Columbia University. She is an affiliate member of the Health Law and Tort Trial and Insurance sections of The Florida Bar, a retired member of the Pennsylvania Bar, and a member of organizations such as the American Bar Association, and the American Society of Law, Medicine & Ethics.

Marni Brooks, BSc, MSW, MD, CCFP, FCFP

Marni Brooks, BSc, MSW, MD, CCFP, FCFP
Staff Physician, New York General Hospital, Toronto, Ontario, Canada
Chair, Ontario Medical Association Medical Interest Group in Cannabinoid Medicine  Dr. Marni Brooks began her education at McGill university where she completed her Bachelor of Science degree, majoring in psychology and focused her thesis in the area of pediatric pain. She was then sponsored by a physician in Sydney, Australia to assist in his pediatric pain research. 

Upon her return to Canada, she completed a Master of Social Work degree where she spent years of training studying women's health and addiction as field placements. Her interest in addiction continued after she completed her medical degree and family medicine residency at the University of Toronto. 

She is now a Fellow in Family Medicine and, until now, has explored working in the areas of family medicine, sleep medicine, addiction medicine and cannabinoid medicine. Dr. Brooks also sat on the OMA Executive of the Section on Addiction Medicine for nearly a decade where she assisted with negotiations with the Ministry of Health on behalf of the members in her section. Most recently, she founded and is the Chair of the OMA Medical Interest Group in Cannabinoid Medicine, the first such group in the country.

Dr. Brooks currently focuses her work in Cannabinoid Medicine, her two main interests. She hopes to help educate her peers, the community and patients, as well as advocate for them, on the benefits of cannabis for a variety of health conditions, either as sole therapy or in conjunction with other treatments. Other experiences in Cannabinoid Medicine include speaking on the Northwinds panel for insurance providers and acting as an expert witness on the safety and medical uses of cannabis in a sentencing hearing.

Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC

Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC
Director of Women Cardiovascular Health Research
Associate Director of Preventive Cardiology
Associate Professor in the Division of Cardiology
Johns Hopkins University School of Medicine
Co-Director, IMPACT Center at JHU
(Improving Participation Among diverse populations in Cardiovascular clinical Trials)
Co-Editor in Chief, American Journal of Preventive Cardiology
Baltimore, MD Erin D. Michos, MD is an Associate Professor in the Division of Cardiology at the Johns Hopkins School of Medicine, with joint appointment in Epidemiology at the School of Public Health. She is the Director of Women’s Cardiovascular Health Research and the Associate Director of Preventive Cardiology at Johns Hopkins University.

Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >650 publications and 11 book chapters. Her clinical and research is focused on (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardiometabolic diseases (4) Coronary artery calcium, inflammation, and other biomarkers of cardiovascular risk.

She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology and an Associate Editor for Circulation. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She is the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards.

Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at Johns Hopkins Hospital, and a Master of Health Science degree at Johns Hopkins School of Public Health.

Our staff can assist you with all your travel arrangements.

Questions? Call us at 800-422-0711.
We can assist you with all your travel arrangements. We'd be happy to help you plan your flights, hotels or tours before and/or after your cruise conference.

Cruise Itinerary

DATE PORT OF CALL ARRIVE DEPART
Sat Dec 28 Ft. Lauderdale, Florida
- 3:30 pm
Sun Dec 29 *At Sea - Cruising
- -
Mon Dec 30 *At Sea - Cruising
- -
Tue Dec 31 Basseterre, St. Kitts
8:00 am 6:00 pm
Wed Jan 01 Tortola, British Virgin Islands
7:00 am 2:30 pm
Thu Jan 02 Puerto Plata, Dom. Rep.
11:30 am 6:00 pm
Fri Jan 03 *At Sea - Cruising
- -
Sat Jan 04 Ft. Lauderdale, Florida
7:00 am -
*Tentative course schedule, actual class times may differ.

Ports of Call

Ft. Lauderdale, Florida - There is an abundance of things to see and do in the Ft. Lauderdale area: visit the newly redesigned Ft. Lauderdale Beach and cafes, stroll the historic Riverwalk, shop the luxurious stores on Las Olas Boulevard or adventure to the Everglades for an intriguing air boat excursion.

At Sea - Cruising - Cruising

Basseterre, St. Kitts - The island England zealously defended from Brimstone Hill, the "Gibraltar of the West Indies." In Basseterre, a mini-London, there's Piccadilly Circus to shop and a gingerbread version of Big Ben by which to check the hour.

Tortola, British Virgin Islands -  Besides being one of the most scenic islands in the Caribbean, Tortola also has a fascinating cultural and historical side. For a glimpse into the island’s colonial past, visit the Virgin Islands Folk Museum. The restored house was once the family home of shipwright, Joseph Wilfred Penn and features a deep collection of Arawak and Carib pottery and stone tools, as well as plantation artifacts. Hike along the seven available walking trails in Sage Mountain National Park for stunning panoramic views of the island and the surrounding natural habitat. Snorkeling in the crystal-clear Caribbean Sea and a rum tasting at Callwood Rum Distillery are essential on a cruise to Tortola. Sample the delicious curries, spicy soups, and sumptuous shellfish dishes available in abundance at local restaurants and many snack shacks around the island.

Puerto Plata, Dom. Rep. - In Puerto Plata, you’ll be greeted by verdant mountains, pristine beaches, and nature-filled adventures. Go for a swim at the awe-inspiring 27 Waterfalls complex. Hike through the lush, protected jungle of El Choco National Park, enjoying the park’s two lagoons. Swim with dolphins at World Ocean, the largest manmade dolphin habitat in the world, or grab a kayak and head out on the water at Manatee Reserve.

For history buffs, tour the Fortress of San Felipe and travel back in time to Spanish occupation. Don’t leave the Domincan Republic without sampling locally distilled rum or delicacies like la bandera and mofongo.

Our staff can assist you with all your travel arrangements.

Questions? Call us at 800-422-0711.
We can assist you with all your travel arrangements. We'd be happy to help you plan your flights, hotels or tours before and/or after your cruise conference.
SHORE EXCURSIONS
Please note that our shore excursions are operated separately and
independently of those offered by the cruise line.
©2019 - University at Sea®